Buprenorphine is considered a standard-of-care option for opioid use disorder during pregnancy — this page covers what that actually means in practice.
Why medication treatment is recommended over stopping opioids entirely during pregnancy: Untreated opioid withdrawal during pregnancy carries real risk to the pregnancy. Medication treatment — buprenorphine or methadone — is considered safer than either continued unregulated opioid use or unsupervised withdrawal.
What to expect for the baby: Some infants exposed to buprenorphine (or methadone) during pregnancy experience neonatal opioid withdrawal syndrome (NOWS) after birth — this is a recognized, generally manageable condition that hospital staff are prepared to monitor and treat, not a sign that treatment was the wrong choice. It’s a different and generally less severe picture than withdrawal from unregulated opioid use.
Suboxone vs. Subutex during pregnancy: Some providers prefer the buprenorphine-only formulation (Subutex) during pregnancy to avoid the naloxone component, though Suboxone is also used by many providers — this is worth discussing directly with your OB and addiction medicine provider together. Suboxone vs. Subutex article
Breastfeeding: Buprenorphine is generally considered compatible with breastfeeding, though this should be confirmed with your specific care team given individual circumstances.
The most important message: If you’re pregnant and using opioids, starting treatment is one of the most protective things you can do for both yourself and the pregnancy — this isn’t a situation where stigma or fear of judgment should delay reaching out. finding a buprenorphine prescriber
Medically reviewed by [pending]. Sources: ACOG and ASAM joint guidance on opioid use disorder in pregnancy, SAMHSA TIP 63.